315 assets in Malignant Pancreatic Neoplasm

Therapeutic assets addressing Malignant Pancreatic Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Shr-A1904 Malignant Pancreatic Neoplasm	Shanghai Hengrui Pharmaceutical Co., Ltd.	P1	CC (41)
5P12-RANTES Malignant Pancreatic Neoplasm	Orion Biotechnology Polska Sp. z o.o.	P1	C (39)
64Cu-Tz-SarAr Malignant Pancreatic Neoplasm	Memorial Sloan Kettering Cancer Center	P1	C (39)
89zr-dfo-n-suc-c9scfv Malignant Pancreatic Neoplasm	Var2 Pharmaceuticals	Early P1	C (39)
89Zr-DFO-N-Suc-F8scFv Malignant Pancreatic Neoplasm	Var2 Pharmaceuticals	Early P1	C (39)
Adagrasib Malignant Pancreatic Neoplasm	M.D. Anderson Cancer Center	P1	C (39)
ak112 Malignant Pancreatic Neoplasm	Akeso	P1	C (39)
ak154 Malignant Pancreatic Neoplasm	Akeso	P1	C (39)
Aquocobalamin Malignant Pancreatic Neoplasm	General Oncology, Inc.	P1	C (39)
Camustine Malignant Pancreatic Neoplasm	General Oncology, Inc.	P1	C (39)
Car-Nk Cell Malignant Pancreatic Neoplasm	Zhejiang University	Early P1	C (39)
Cea Car-T Cells Malignant Pancreatic Neoplasm	Chongqing Precision Biotech Co., Ltd	P1	C (39)
dk210 Malignant Pancreatic Neoplasm	DEKA Biosciences	P1	C (39)
Enzalutamide Malignant Pancreatic Neoplasm	Nuvation Bio Inc.	P1	C (39)
Erx-315 Malignant Pancreatic Neoplasm	EtiraRx Australia Pty Ltd	P1	C (39)
[Ga-68]Mtp220 Malignant Pancreatic Neoplasm	Qiubai Li	Early P1	C (39)
hu5B1-TCO Malignant Pancreatic Neoplasm	Memorial Sloan Kettering Cancer Center	P1	C (39)
ic9-car.b7-h3 t cells Malignant Pancreatic Neoplasm	UNC Lineberger Comprehensive Cancer Center	P1	C (39)
Immunoglobulin G1 [De-C-Terminal-Lysine], Anti-(Human Epidermal Growth Factor Receptor) (Human-Mus Musculus Clone Bca101 ?1-Chain), Disulfide With Human-Mus Musculus Clone Bca101 ?-Chain Fusion Protein With Peptide Linker (Ggggs)3 Fusion Protein With 23-159-Transforming Growth Factor ? Receptor Tgfbr2 (Human), Dimer Malignant Pancreatic Neoplasm	Bicara Therapeutics	P1	C (39)
IPH5301 Malignant Pancreatic Neoplasm	Institut Paoli-Calmettes	P1	C (39)
Ivonescimab Malignant Pancreatic Neoplasm	Akeso	P1	C (39)
Lixumistat Malignant Pancreatic Neoplasm	M.D. Anderson Cancer Center	P1	C (39)
LXP1788 Malignant Pancreatic Neoplasm	LaunXP Biomedical Co., Ltd.	P1	C (39)
Melphalan Malignant Pancreatic Neoplasm	General Oncology, Inc.	P1	C (39)
Metarrestin Malignant Pancreatic Neoplasm	National Cancer Institute (NCI)	P1	C (39)
MGC026 Malignant Pancreatic Neoplasm	MacroGenics	P1	C (39)
Moma-313 Malignant Pancreatic Neoplasm	MOMA Therapeutics	P1	C (39)
Monomethylauristatin E Malignant Pancreatic Neoplasm	The First Affiliated Hospital of Air Force Medicial University	Early P1	C (39)
Neldaleucel Malignant Pancreatic Neoplasm	Marker Therapeutics, Inc.	P1	C (39)
Nuv-868 Malignant Pancreatic Neoplasm	Nuvation Bio Inc.	P1	C (39)
Ono-7913 Malignant Pancreatic Neoplasm	Ono Pharmaceutical Co., Ltd.	P1	C (39)
QXL138AM Malignant Pancreatic Neoplasm	Nammi Therapeutics Inc	P1	C (39)
Tamnorzatinib Malignant Pancreatic Neoplasm	Ono Pharmaceutical Co., Ltd.	P1	C (39)
Torl-2-307-Adc Malignant Pancreatic Neoplasm	TORL Biotherapeutics, LLC	P1	C (39)
Torl-2-307-Mab Malignant Pancreatic Neoplasm	TORL Biotherapeutics, LLC	P1	C (39)
Alectinib Malignant Pancreatic Neoplasm	OHSU Knight Cancer Institute	Early P1	C (38)
Alpelisib Malignant Pancreatic Neoplasm	OHSU Knight Cancer Institute	Early P1	C (38)
Anastrozole Malignant Pancreatic Neoplasm	OHSU Knight Cancer Institute	Early P1	C (38)
Azenosertib Malignant Pancreatic Neoplasm	OHSU Knight Cancer Institute	Early P1	C (38)
Claudin18.2-Targeted Car-Dcs Malignant Pancreatic Neoplasm	Hainan Cancer Hospital	Early P1	C (38)
Claudin18.2 Targeted Car-T Cells Malignant Pancreatic Neoplasm	Hainan Cancer Hospital	Early P1	C (38)
Eribulin Malignant Pancreatic Neoplasm	OHSU Knight Cancer Institute	Early P1	C (38)
Fulvestrant Malignant Pancreatic Neoplasm	OHSU Knight Cancer Institute	Early P1	C (38)
Hyaluronidase Zzxf Malignant Pancreatic Neoplasm	OHSU Knight Cancer Institute	Early P1	C (38)
Personalized Neoantigen Tumor Vaccine Malignant Pancreatic Neoplasm	Ruijin Hospital	Early P1	C (38)
Saruparib Malignant Pancreatic Neoplasm	OHSU Knight Cancer Institute	Early P1	C (38)
Vinorelbine Ditartrate Malignant Pancreatic Neoplasm	OHSU Knight Cancer Institute	Early P1	C (38)
Neoantigen Dna Vaccine Malignant Pancreatic Neoplasm	Centre Georges Francois Leclerc	P1	C (37)
Nisevokitug Malignant Pancreatic Neoplasm	Kimberly Perez, MD	P2	C (37)
177Lu-DOTA-ABM-5G Malignant Pancreatic Neoplasm	University of California, Davis	Early P1	C (36)

Showing 251 to 300 of 315 assets

PreviousPage 6 of 7Next